- Home
- Obstetrics & Gynaecology
- Nipocalimab in Early-Onset Severe Hemolytic Disease of the Fetus and Newborn
2mo3 min read
Medical Article
Introduction Early-onset severe hemolytic disease of the fetus and newborn (HDFN) is a rare, potentially life-threatening condition caused by maternal alloantibodies most commonly anti-D or anti-K crossing the placenta and destroying fetal red blood cells (1). This can result in severe fetal anemia, hydrops fetalis, preterm birth, and perinatal mor

Nipocalimab in Early-Onset Severe Hemolytic Disease of the Fetus and Newborn
Similar Content

Rubella Syndrome in Neonate
1401 Reached12 Comments9 Likes

Pregnant Woman with HIV-1 Infection
747 Reached1 Likes

Use of Clindamycin for Managing Bacterial Vaginosis
11214 Reached29 Comments8 Likes

Chronic Hyperplastic Candidiasis Of The Oral Mucosa
858 Reached9 Comments11 Likes

Case of Adolescent with Severe Macrocytic Anaemia
52905 Reached502 Comments51 Likes
